Merck MRK
NYSE MRK
$146.77 -0.36 (-0.24%)
At close: Sep 18, 2026 · 4:00 PM EDT

Merck (MRK) Interest & Investment Income (2010 - 2013)

Merck's (MRK) quarterly Interest & Investment Income came in at $57.0 million in Q1 2013, up 3.64% year-over-year from $55.0 million in Q1 2012, and down 24.0% quarter-over-quarter from $75.0 million in Q4 2012.

Analysis

Merck (MRK) Interest & Investment Income (2010 - 2013) Analysis & Trends

Merck (MRK) has reported Interest & Investment Income for 4 consecutive years, with $57.0 million the latest figure, recorded in Q1 2013.

  • On a quarterly basis, Interest & Investment Income rose 3.64% year-over-year to $57.0 million in Q1 2013; TTM through Mar 2013 was $234.0 million, a N/A change from a year earlier, with the FY2012 full-year figure at $232.0 million, up 60.0% from the prior year.
  • Interest & Investment Income was $57.0 million for Q1 2013 at Merck, down from $75.0 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $75.0 million in Q4 2012 and troughed at $31.0 million in Q4 2010.
  • A 4-year average of $48.6 million and a median of $47.0 million in 2012 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income jumped 74.42% in 2012 and rose 3.64% in 2013, its largest moves.
  • Over 4 years, Interest & Investment Income stood at $31.0 million in 2010, then jumped by 38.71% to $43.0 million in 2011, then jumped by 74.42% to $75.0 million in 2012, then decreased by 24.0% to $57.0 million in 2013.
  • The last three Interest & Investment Income figures came in at $57.0 million (Q1 2013), $75.0 million (Q4 2012), and $47.0 million (Q3 2012), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 219.00 Mn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -679.00 Mn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 89.50 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 35.58 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 27.90 Mn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn 38.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 57.00 Mn
Dec 31, 2012 75.00 Mn
Sep 30, 2012 47.00 Mn
Mar 31, 2012 55.00 Mn
Dec 31, 2011 43.00 Mn
Sep 30, 2011 32.00 Mn
Dec 31, 2010 31.00 Mn